3Simonsen GS,Smabrekke L,Monnet DL,et al. Prevalence of resistance to ampicillin,gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimems and use of antimicrobials in five Nordic hospitals[J]. J Antimicrob Chetrother, 2003,51 (2) :323. 被引量:1
5[1]National Committee for Clinical Laboratory Standard. Performance standards for antimicrobial susceptibility testing. ninth informational supplement [S]. M100-S9 Vol 19. Pennsylvania:NCCLS, NO1, January 1999 被引量:1
6[7]World Health Organization. WHO Prevention of hospital-acquired infections. WHO/CDS/CSR/EPH/2002,12 被引量:1
7[9]World Health Organization. WHO Global strategy for containment of antimicrobial resistance. WHO/CDS/CSR/DRS/2001,2 被引量:1
8[4]Hirakata Y, Izumikawa K, Yamaguchi K, et al.Rapid detection and evolution of clinical characteristics of emerging multiple-drug-resistant Gram-negative rods carrying the metallo-β-lactamase gene blaIMP[J]. Antimicrob Agents Chemother, 1998, 42: 2006-2011. 被引量:1
9[5]Arakawa Y, Shibata N, Shibayama K, et al. Convenient test for screening metallo-β-lactamase-producing Gram-negative bacteria by using thiol compounds[J]. J Clin Microbiol, 2000, 38(1): 40-43. 被引量:1
10[6]National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard[S]. Fifth edition. Wayne Pennsylvania National Committee for Clinical Laboratory Standards. 2001. 被引量:1